Comparing the current results to its competitors, Tactile Systems Technology Inc reported Revenue increase in the 2 quarter 2026 by 8.76 % year on year. The revenue growth was below Tactile Systems Technology Inc 's competitors' average revenue growth of 9.07 %, achieved in the same quarter.
Tactile Systems Technology Inc Net Income in the 2 quarter 2026 grew year on year by 142%, faster than the Tactile Systems Technology Inc 's competitors average income growth of 39.43 %
Tactile Systems Technology Inc 's Comment on Competition and Industry Peers
The pneumatic compression pump market includes several manufacturers and distributors. Key manufacturing competitors include Bio Compression Systems, Inc. and Lympha Press USA. The company is the only pneumatic compression home-therapy device provider with a significant U.S. market presence supported by a direct sales force. Competitors primarily rely on durable medical equipment (DME) distribution intermediaries, which affects their margins and limits investment in clinical evidence and product development. Transitioning to a direct-to-patient and direct-to-provider sales model would require competitors to obtain national accreditation, state licensing, and Medicare billing privileges.
Publicly Traded Peers of Tactile Systems Technology Inc
Clearpoint Neuro Inc Share Performance
-10.23%
Over The Past 5 Days
Clearpoint Neuro Inc
Profile
Clearpoint Neuro Inc's business model revolves around providing advanced deep brain stimulation (DBS) solutions for the treatment of neurological disorders. It focuses on developing and commercializing innovative medical devices, software, and services that enable precise and accurate targeting for electrode placement during neurosurgical procedures.
Electrocore Inc operates on a business model that focuses on developing and commercializing innovative neuromodulation therapies. They utilize non-invasive vagus nerve stimulation (nVNS) to offer patients drug-free solutions for various medical conditions. The company's approach involves leveraging their understanding of the human body's electrochemical signaling system to provide targeted and effective treatments across multiple therapeutic areas.
Inspire Medical Systems Inc operates on a direct-to-patient business model, focused on developing and commercializing innovative medical devices for patients suffering from sleep apnea. The company's business model revolves around providing a unique therapy solution through the development of its proprietary Inspire therapy system, which includes a surgically implanted device that stimulates the upper airway during sleep. By targeting both physicians and patients, Inspire Medical Systems aims to improve clinical outcomes and bring relief to those with unmet needs in the field of sleep apnea treatment.
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
3M Company operates a diversified business model by offering innovative solutions across multiple segments, including healthcare, safety and industrial, transportation, and consumer goods. The company leverages its extensive portfolio of patents and deep customer relationships to drive product development and market responsiveness, focusing on delivering value across various industries.
Sources:
Tactile Systems Technology Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Tactile Systems Technology Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
